Dendreon Corp fka DNDNQ

[walldiver]

I don't know if HR will be as relevant as the p value. As I recall, the HR for 9902A wasn't bad, something like 0.77-0.79 if calculated the same way that every biopharma company in the world except DNDN does it. Taxotere's pivotal Phase III that got it approval in AIPC had a similar HR, but Tax's p value was <0.01 while the Provenge p value in 9902A was 0.33.